Pharmedium Services lidocaine HCl 1%, 10 mg per mL (50 mg per 5 mL), Preservative Free, 5 mL recall — FDA D-0064-2017
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Browse U.S. drug recall enforcement reports from the FDA in a structured, searchable format. Review the recalled product, reason, firm, status, dates, distribution information and FDA classification when available.
10,690 detailed records are currently available in this category.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters
Subpotent Drug: confirmed subpotency in one lot of this product that was packaged and stored in syringes.
Subpotent Drug and Stability Data Does Not Support Expiry: confirmed subpotency and potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the…
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Marketed without an Approved NDA/ANDA; FDA analysis found them to contain sibutramine and phenolphthalein
Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Marketed without an Approved NDA/ANDA; FDA analysis found them to contain sibutramine and phenolphthalein
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry:potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
Failed Dissolution Specifications
Labeling: Missing Label-Primary packaging label (i.e. blister card) is blank and contains no product information (e.g. product name, strength, lot number, expiry).
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.